Population impact of stricter adherence to recommendations for pharmacological and lifestyle interventions over one year in patients with coronary heart disease
Open Access
- 1 December 2005
- journal article
- evidence based-public-health-policy-and-practice
- Published by BMJ in Journal of Epidemiology and Community Health
- Vol. 59 (12), 1041-1046
- https://doi.org/10.1136/jech.2005.035717
Abstract
Study objective: To assess the potential number of lives saved associated with the full implementation of aspects of the National Service Framework (NSF) for coronary heart disease (CHD) in England using recently developed population impact measures. Design: Modelling study. Setting: Primary care. Data sources: Published data on prevalence of acute myocardial infarction and heart failure, baseline risk of mortality, the relative risk reduction associated with different interventions and the proportion treated, eligible for treatment and adhering to each intervention. Main results: Adopting the NSF recommendations for pharmacological interventions would prevent an extra 1027 (95% CI 418 to 1994) deaths in post-acute myocardial infarction (AMI) patients and an extra 37 899 (95% CI 25 690 to 52 503) deaths in heart failure patients in the first year after diagnosis. Lifestyle based interventions would prevent an extra 848 (95% CI 71 to 1 614) deaths in post-AMI patients and an extra 7249 (95% CI 995 to 16 696) deaths in heart failure patients. Conclusions: Moving from current to “best” practice as recommended in the NSF will have a much greater impact on one year mortality rates among heart failure patients compared with post-AMI patients. Meeting pharmacological based recommendations for heart failure patients will prevent more deaths than meeting lifestyle based recommendations. Population impact numbers can help communicate the impact on a population of the implementation of guidelines and, when created using local data, could help policy makers assess the local impact of implementing a range of health care targets.Keywords
This publication has 50 references indexed in Scilit:
- Lack of aspirin effect: aspirin resistance or resistance to taking aspirin?American Heart Journal, 2004
- Missing, mediocre, or merely obsolete? An evaluation of UK data sources for coronary heart diseaseJournal of Epidemiology and Community Health, 2003
- Prophylactic treatment after myocardial infarction in primary care: how far can we go?Family Practice, 2003
- The way I see it: House officers need formal career developmentBMJ, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- A population perspective to evidence based medicine: "evidence for population health"Journal of Epidemiology and Community Health, 2002
- Enhancing Drug Compliance in Lipid-Lowering TreatmentArchives of Family Medicine, 2000
- Disease impact number and population impact number: population perspectives to measures of risk and benefit Commentary: DINS, PINS, and things---clinical and population perspectives on treatment effectsBMJ, 2000
- The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart FailureNew England Journal of Medicine, 1999
- Secondary prevention of coronary heart disease in primary care: a healthy heart initiativeQJM: An International Journal of Medicine, 1999